Coordinating Panel on Neuroscience/ Translational Neurology

Neuroscience and Translational Neurology focuses on translating fundamental neuroscience discoveries into practical treatments for brain and nervous system disorders. Typically, this involves a bi-directional "bench-to-bedside" model aiming to narrow the gap between laboratory models and neurological patient care.

Translational research can be divided into five stages (T0-T4), spanning the entire research field from basic science to public health implementation.

T0: Basic Science: investigation offundamental disease mechanisms at the molecular, cellular and neuronal circuit levels, applying in vitro, in vivo or computational experimental models.

T1: Preclinical Research & Proof-of-Concept: early human testing, including phase 1 clinical trials to test feasibility, tolerability, safety and dosing in humans.

T2: Clinical validation: research on the efficacy and safety of diagnostic, therapeutic or monitoring tools and interventions in targeted, larger patient cohorts, often in the context of phase II and phase III clinical trials.

T3: Clinical implementation: Establish clinical guidelines to ensure that treatments with proven efficacy enter standard neurological practice. Investigate implementation, dissemination, and adoption of new and useful diagnostic and monitoring tools and treatments.

T4: Public Health & Population Impact: Research is focused on long-term outcomes and effectiveness across broader communities and dynamic healthcare systems, aiming to ensure equitable health benefits in the population.

Translational neuroscience and neurology are increasingly important because of the high global burden of neurological disorders, that are characterised by heterogeneity, and sometimes disease-agnostic mechanisms. These translational foundations lead to rapidly evolving therapeutic and technological strategies. Strong translational frameworks support biomarker development, patient stratification, target validation, and well-designed clinical trials, ultimately narrowing the gap between experimental findings and real-world clinical benefit.

The Neuroscience and Translational Neurology Coordinating Panel brings together clinician-scientists and basic neuroscientists with complementary expertise, with the aim of improving the quality, interpretability, and clinical impact of translational research.

Given its strongly cross-cutting nature, the panel operates at the interface of other EAN Scientific Panels and Coordinating Panels. It supports shared methodological standards and helps connect disease-focused clinical priorities with mechanistic neuroscience, biomarker science, and emerging technologies. This inherently transversal mission reflects the need for diverse competencies, from experimental models to clinical phenotyping, advanced statistics, and implementation pathways.

The panel also engages with neuroscience partner societies to promote exchange across professional communities.

This collaboration strengthens communication between disciplines and fosters a common language and shared priorities among researchers and clinicians who ultimately work toward the same goal: a deeper understanding of nervous system function and the mechanisms underlying neurological disease.